Skip to main content
OpenTrials

Clinical trial condition

Acute Myeloid Leukemia, in Relapse

Explore clinical trials studying Acute Myeloid Leukemia, in Relapse. Study availability and eligibility vary by location and protocol.

31 public trials 21 recruiting studies
Refine in advanced search Browse all conditions

Acute Myeloid Leukemia, in Relapse trial results

Recruiting

Safety of MT-401-OTS in Patients With Relapsed AML or MDS

NCT06552416

Conditions
Acute Myeloid Leukemia, in Relapse, Hematologic Diseases, Hemic and Lymphatic Diseases, +6 more
Locations
  • City of Hope Center (City of Hope National Medical Center, City of Hope Medical Center) Duarte, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • KU Cancer Center Kansas City, Kansas, United States
View Trial Details
Recruiting

AB8939 in Patients With Relapsed/Refractory Acute Myeloid Leukemia

NCT05211570

Conditions
Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia, in Relapse, Bone Marrow Diseases, +12 more
Locations
  • MD Anderson Cancer Center Houston, Texas, United States
  • Institut Paoli Calmettes Marseille, France
  • National and Kapodistrian University of Athens NKUA · Department of Hematology and Bone marrow Transplantation Unit Athens, Greece
  • General University Hospital of Alicantet (Hospital General Universitario Dr. Balmis de Alicante) Alicante, Spain
View Trial Details
Recruiting

Phase 1 Study of Allo-RevCAR01-T-CD123 in Patients With Selected CD123 Positive Hematologic Malignancies

NCT05949125

Conditions
Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia, in Relapse, Hematologic Diseases, +6 more
Locations
  • Universitätsklinikum Ulm Ulm, Baden-Wurttemberg, Germany
  • Klinikum der Universität München Munich, Bavaria, Germany
  • Universitätsklinikum Würzburg Würzburg, Bavaria, Germany
  • Universitätsklinikum Marburg Marburg, Hesse, Germany
View Trial Details
Recruiting

A Clinical Trial of BP1002 in Patients With Refractory/Relapsed Acute Myeloid Leukemia (AML)

NCT05190471

Conditions
Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia, in Relapse, Hematologic Diseases, +6 more
Locations
  • Scripps Green Hospital La Jolla, California, United States
  • UCLA Medical Center Los Angeles, California, United States
  • Weill Cornell Medical College - NewYork-Presbyterian Hospital New York, United States
  • MD Anderson Cancer Center Houston, Texas, United States
View Trial Details
Recruiting

Study of Iadademstat and Gilteritinib in Patients With R/R AML With FMS-like Tyrosine Kinase Mutation (FLT3 Mut+)

NCT05546580

Conditions
Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia, in Relapse, Hematologic Diseases, +6 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • The University of Arizona Cancer Center - North Campus Tucson, Arizona, United States
  • Sylvester Comprehensive Cancer Center Miami, Florida, United States
  • Miami Cancer Institute Miami, Florida, United States
View all 13 locations
View Trial Details

Related conditions